Merck & Co Inc

NYSE: MRK
$115.63
-$1.54 (-1.3%)
Closing Price on September 23, 2024

MRK Articles

ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game console margins for the next several years. (MarketWatch) Sony also cuts targets for smartphones and camera sales. (Reuters) A complex Irish...
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
On the surface it looks like short sellers are all over the place in the latest short interest report. The April 30 settlement date is after many companies had their earnings reports. We saw some...
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc....
This week should mark the climax of first quarter corporate earnings season. It will be a full week for the earnings calendar, along with key economic events and some corporate annual meetings to...
While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists are casting a wary eye at the looming May 1 date. In a new...
Jon OggShort sellers have increased their bets against some of the defensive high-yield dividend stocks, while paring down in others. As you will see, the dividend and stock performance matter here....
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Jon OggShort sellers may be getting smarter about all the inflows of capital heading into dividend stocks. The short interest fell in many of the names, but investors should understand that this...
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is a...
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke,...
Jon OggShort sellers have kept their attack up against the high-dividend stocks, perhaps indicating that many investors believe that the bull market may turn back toward growth rather than paying a...
Jon OggShort sellers have continued to by and large increase their short-sale bets against the quality high-yield dividend stocks. The price gains must lead short sellers to believe that the yields...